CareDx, Inc. (CDNA)
47.50
-1.11
(-2.28%)
USD |
NASDAQ |
Aug 24, 16:00
47.51
+0.01
(+0.02%)
After-Hours: 05:19
CareDx Price to Book Value : 5.746 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.746 |
| August 21, 2026 | 5.880 |
| August 20, 2026 | 5.684 |
| August 19, 2026 | 5.626 |
| August 18, 2026 | 5.586 |
| August 17, 2026 | 5.610 |
| August 14, 2026 | 5.482 |
| August 13, 2026 | 5.731 |
| August 12, 2026 | 5.723 |
| August 11, 2026 | 5.713 |
| August 10, 2026 | 5.694 |
| August 07, 2026 | 5.648 |
| August 06, 2026 | 5.420 |
| August 05, 2026 | 5.504 |
| August 04, 2026 | 5.696 |
| August 03, 2026 | 5.788 |
| July 31, 2026 | 5.287 |
| July 30, 2026 | 4.609 |
| July 29, 2026 | 4.283 |
| July 28, 2026 | 4.324 |
| July 27, 2026 | 4.398 |
| July 24, 2026 | 4.493 |
| July 23, 2026 | 4.550 |
| July 22, 2026 | 4.570 |
| July 21, 2026 | 4.662 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.641 |
| July 17, 2026 | 4.806 |
| July 16, 2026 | 4.880 |
| July 15, 2026 | 3.599 |
| July 14, 2026 | 3.500 |
| July 13, 2026 | 3.479 |
| July 10, 2026 | 3.449 |
| July 09, 2026 | 3.521 |
| July 08, 2026 | 3.333 |
| July 07, 2026 | 3.424 |
| July 06, 2026 | 3.515 |
| July 02, 2026 | 3.531 |
| July 01, 2026 | 3.538 |
| June 30, 2026 | 3.448 |
| June 29, 2026 | 4.788 |
| June 26, 2026 | 4.713 |
| June 25, 2026 | 4.554 |
| June 24, 2026 | 4.437 |
| June 23, 2026 | 4.108 |
| June 22, 2026 | 4.097 |
| June 18, 2026 | 4.281 |
| June 17, 2026 | 3.840 |
| June 16, 2026 | 3.802 |
| June 15, 2026 | 3.938 |
| June 12, 2026 | 3.756 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Natera, Inc. | 25.84 |
| Caris Life Sciences, Inc. | 12.48 |
| Myriad Genetics, Inc. | 0.9595 |
| BioRestorative Therapies, Inc. | 1.795 |
| Exagen, Inc. | 15.15 |
Price to Book Value Related Metrics
| PE Ratio | 22.89 |
| PS Ratio | 5.480 |
| PEG Ratio | 0.1972 |
| Price to Free Cash Flow | 29.88 |
| Price | 47.50 |
| Earnings Yield | 4.37% |
| Market Cap | 2.445B |
| PEGY Ratio | 0.1972 |
| Normalized PE Ratio | 22.47 |